The effect of dosing regimen on the pharmacokinetics of risedronate administered to healthy subjects.

被引:0
|
作者
Mitchell, DY [1 ]
Eusebio, RA [1 ]
Heise, MA [1 ]
Pallone, KA [1 ]
Clay, ME [1 ]
Russell, DA [1 ]
Melson, CW [1 ]
机构
[1] PROCTER & GAMBLE CO,CINCINNATI,OH 45242
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:M661 / M661
页数:1
相关论文
共 50 条
  • [1] The effect of dosing regimen on the pharmacokinetics of risedronate
    Mitchell, DY
    Heise, MA
    Pallone, KA
    Clay, ME
    Nesbitt, JD
    Russell, DA
    Melson, CW
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (04) : 536 - 542
  • [2] THE EFFECT OF MUTIPLE DOSING OF GINKO BILOBA ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CILOSTAZOL IN HEALTHY SUBJECTS.
    Yeo, C.
    Cho, H.
    Park, S.
    Lee, B.
    Shon, J.
    Shin, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S43 - S43
  • [3] EVALUATE THE EFFECT OF ORAL DOSES OF IBREXAFUNGERP ON THE PHARMACOKINETICS OF DABIGATRAN ADMINISTERED ORALLY TO HEALTHY SUBJECTS.
    Azie, N.
    Angulo, D.
    Wabnitz, P.
    Murphy, G.
    Ghahramani, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [4] EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF ERTUGLIFLOZIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Liang, Y.
    Matschke, K.
    Shi, H.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Cutler, D. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [5] Pharmacokinetics of galantamine and risperidone administered alone and in combination in healthy elderly subjects.
    Zhao, Q
    Zhou, H
    Huang, F
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P97 - P97
  • [6] Tolerability and pharmacokinetics of fixed doses of buspirone administered transdermally to healthy subjects.
    Fulmor, IE
    Szylleyko, OJ
    Kollia, GD
    Ford, NF
    Salazar, DE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 167 - 167
  • [7] INDUCTIVE EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF VORICONAZOLE IN HEALTHY SUBJECTS.
    Lee, S.
    Shin, D.
    Kim, S.
    Ji, S. C.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Jang, I. J.
    Yu, K. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S3 - S4
  • [8] Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
    Lee, Y
    Orlowski, LH
    Michiels, N
    Petty, KJ
    Goldberg, MR
    Dru, J
    Chavez-Eng, CM
    Constanzer, M
    Murphy, G
    Gottesdiener, K
    Hesney, M
    Feuring, M
    Wehling, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P66 - P66
  • [9] Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.
    Park, J
    Kim, K
    Jung, W
    Kim, S
    Shin, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P34 - P34
  • [10] Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone in healthy subjects.
    Lebrun-Vignes, B
    Chosidow, O
    Diquet, B
    Levron, JC
    Herson, S
    Corbrion-Archer, V
    Puech, AJ
    Warot, D
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 683 - 683